Respiratory Medicine
Volume 97, Issue 1 , Pages 20-26, January 2003

Cost–effectiveness of salmeterol in patients with chronic obstructive pulmonary disease: an economic evaluation

  • PW JONES

      Affiliations

    • St George's Hospital Medical School, London, U.K.
    • ,
  • K WILSON

      Affiliations

    • GlaxoSmithKline R&D, Greenford, Middlesex, U.K.
    • ,
  • S SONDHI

      Affiliations

    • GlaxoSmithKline R&D, Greenford, Middlesex, U.K.

Received 5 March 2002; accepted 23 July 2002.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0954-6111(02)91425-3

doi:10.1053/rmed.2002.1425

Respiratory Medicine
Volume 97, Issue 1 , Pages 20-26, January 2003

Article Tools